Feb 25 (Reuters) - Procept Biorobotics Q4 revenue USD 76.383 million vs. IBES estimate USD 94.1 million.
- Q4 adjusted EBITDA USD -19.013 million vs. IBES estimate USD -2.8 million
- outlook FY revenue USD 390-410 million
- outlook FY gross margin 65%
- outlook FY revenue growth 27-33%
- outlook FY adjusted EBITDA USD -30 to -17 million